Veracyte | VCYT - Ebit


Veracyte reported $23.96M in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
Agenus USD 15.05M 656K Mar/2026
Agilent USD 444M 45M Jun/2026
Anika Therapeutics USD 646K 3.88M Dec/2025
Arrowhead Research USD -154.34M 13.08M Jun/2026
Bruker USD 69.6M 59.4M Jun/2026
Heron Therapeutics USD 38K 3.83M Dec/2025
Illumina USD 260M 21M Jun/2026
Intrexon USD -26.3M 2.91M Jun/2024
Karyopharm Therapeutics USD -26.76M 8.92M Mar/2026
Laboratory Of America USD 456.7M 46.6M Jun/2026
Ligand Pharmaceuticals USD 56.62M 3.7M Jun/2026
Myriad Genetics USD -3M 20.3M Dec/2025
Rigel Pharmaceuticals USD 447K 1.52M Jun/2024
Roche Holding CHF 11.46B 1.91B Jun/2026
Siemens EUR 3.19B 509M Jun/2026
Sonic Healthcare AUD 423.94M 80.3M Dec/2024
Thermo Fisher Scientific USD 2.18B 273M Jun/2026
Veracyte USD 23.96M 4.88M Jun/2026
Waters USD 10M 138M Jun/2026